In a review of 1057 consecutive prostatectomies of which 95% were performed transurethrally, carcinoma was present in 11.8%. There were 10 deaths within a month of operation (0.9%), 9 of these patients having been exceptionally old and unfit. The rate of complications and the end results appear to justify using transurethral resection as the method of choice for prostatectomy whenever it is feasible.

In a retrospective study of 185 patients with transitional cell carcinoma of the renal pelvis and ureter, of whom 127 were treated by total nephroureterectomy and 58 by conservative resection, the survival of those with superficial well differentiated tumours was greater than 90% in each group. When urothelium was left behind after conservative resection, there was a 22% rate of recurrence on the same side but this almost only occurred when the original tumour had been multifocal. Post-operative radiotherapy did not improve survival.

Seven hundred and four patients with bladder cancer treated by radiotherapy at the London Hospital between 1965 and 1974 have been followed for a minimum period of 5 years. Invasive tumours were usually treated by radical radiotherapy. Cystectomy was reserved for patients whose tumours did not respond to radiation, recurred later on, or who developed complications from radiotherapy. The crude 5-year survival rate for T3 tumours in this series was 38%--similar to that obtained in other centres using pre-operative radiation followed by cystectomy, but this overall figure conceals the important difference between 2 distinct tumour populations. Nearly half of these tumours appear to be radiosensitive, giving a 56% crude 5-year survival rate for T3 tumours. The remainder are radioinsensitive, with only a 17% crude 5-year survival rate for T3 tumours. When there is a good initial response to radiotherapy there would seem to be no necessity to insist upon cystectomy.

The histories of 332 T1 bladder cancer patients were studied to determine the natural history in this tumour population. Each was followed for at least 5 years or to earlier tumour death and the approach to treatment was conservative. Patients were potentially at serious risk of disease progression and death if they presented with tumours of G2 or G3 grade and grew new ones again after treatment or if they exhibited a continuous high level of tumor neogenesis. Fourteen developed urothelial tumours beyond the bladder, evidence of widespread urothelial instability. Tumour deaths accounted for only 12% of the series, justifying a conservative approach to treatment, and a further 25% died from unrelated causes. Those remaining tumour-free at 5 years had a low malignant potential and their natural history supported discontinuing routine cystoscopy after that time.